Poorly controlled cholesterol is associated with cognitive impairment in T2DM: A resting-state fMRI study

Lipids in Health and Disease

Volumn 14, Issue 1, 2015, Pages

  Xia, Wenqing ^a,b,c   Zhang, Bin ^d   Yang, Yang ^d   Wang, Pin ^a   Yang, Yue ^a   Wang, Shaohua ^a,b  

^a AFFILIATED ZHONGDA HOSPITAL OF SOUTHEAST UNIVERSITY   (China)

^b MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d Outpatient Depart Panda Group Community Health Service Centre   (China)

Author keywords

Cholesterol; Cognitive impairment; Functional connectivity; Resting state fMRI; Type 2 diabetes mellitus

Indexed keywords

C PEPTIDE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; POORLY CONTROLLED CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ANTERIOR CINGULATE; ARTICLE; ATTENTION DISTURBANCE; BOLD SIGNAL; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; EXECUTIVE FUNCTION; FEMALE; FUNCTIONAL CONNECTIVITY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HIPPOCAMPUS; HUMAN; INFERIOR PARIETAL LOBULE; INSULA; LIPOPROTEIN BLOOD LEVEL; MALE; MIDDLE AGED; MIDDLE FRONTAL GYRUS; MIDDLE TEMPORAL GYRUS; NERVOUS SYSTEM FUNCTION; NEUROIMAGING; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTERIOR CINGULATE; PRECUNEUS; PSYCHOLOGIC TEST; RESTING STATE NETWORK; CASE CONTROL STUDY; COGNITION DISORDERS; COMPLICATION; FUNCTIONAL NEUROIMAGING; HYPERCHOLESTEROLEMIA; NERVE TRACT; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY;

CASE-CONTROL STUDIES; COGNITION DISORDERS; DIABETES MELLITUS, TYPE 2; FEMALE; FUNCTIONAL NEUROIMAGING; HIPPOCAMPUS; HUMANS; HYPERCHOLESTEROLEMIA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEURAL PATHWAYS; NEUROPSYCHOLOGICAL TESTS;

EID: 85018121275     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/s12944-015-0046-x     Document Type: Article

References (43)

1. McCrimmon RJ, Ryan CM, Frier BM. Diabetes and cognitive dysfunction. Lancet. 2012;379:2291-9.
2. Luchsinger JA, Reitz C, Patel B, Tang M-X, Manly JJ, Mayeux R. Relation of diabetes to mild cognitive impairment. Arch Neurol. 2007;64:570.
3. Biessels GJ, Deary IJ, Ryan CM. Cognition and diabetes: a lifespan perspective. Lancet Neurol. 2008;7:184-90.
4. Braak H, Braak E. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol Aging. 1995;16:271-8.
5. O'Sullivan M, Ngo E, Viswanathan A, Jouvent E, Gschwendtner A, Saemann PG, et al. Hippocampal volume is an independent predictor of cognitive performance in CADASIL. Neurobiol Aging. 2009;30:890-7.
6. Gold S, Dziobek I, Sweat V, Tirsi A, Rogers K, Bruehl H, et al. Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes. Diabetologia. 2007;50:711-9.
7. Bruehl H, Wolf OT, Sweat V, Tirsi A, Richardson S, Convit A. Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus. Brain Res. 2009;1280:186-94.
8. Stranahan AM, Arumugam TV, Cutler RG, Lee K, Egan JM, Mattson MP. Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Nat Neurosci. 2008;11:309-17.
9. Reitz C, Luchsinger J, Tang M-X, Manly J, Mayeux R. Impact of plasma lipids and time on memory performance in healthy elderly without dementia. Neurology. 2005;64:1378-83.
10. Li G, Shofer J, Kukull W, Peskind E, Tsuang D, Breitner J, et al. Serum cholesterol and risk of Alzheimer disease a community-based cohort study. Neurology. 2005;65:1045-50.
11. Kivipelto M, Helkala E-L, Hänninen T, Laakso M, Hallikainen M, Alhainen K, et al. Midlife vascular risk factors and late-life mild cognitive impairment a population-based study. Neurology. 2001;56:1683-9.
12. Sparks DL, Kryscio RJ, Connor DJ, Sabbagh MN, Sparks LM, Lin Y, et al. Cholesterol and cognitive performance in normal controls and the influence of elective statin use after conversion to mild cognitive impairment: results in a clinical trial cohort. Neurodegener Dis. 2010;7:183-6.
13. Solomon A, Kåreholt I, Ngandu T, Winblad B, Nissinen A, Tuomilehto J, et al. Serum cholesterol changes after midlife and late-life cognition twenty-one-year follow-up study. Neurology. 2007;68:751-6.
14. Van Exel E, de Craen AJ, Gussekloo J, Houx P, Bootsma-van der Wiel A, Macfarlane PW, et al. Association between high density lipoprotein and cognitive impairment in the oldest old. Ann Neurol. 2002;51:716-21.
15. Yaffe K, Barrett-Connor E, Lin F, Grady D. Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol. 2002;59:378.
16. Williamson JD, Launer LJ, Bryan RN, Coker LH, Lazar RM, Gerstein HC, et al. Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels: a randomized clinical trial. JAMA Int Med. 2014;174:324-33.
17. Goh DA, Dong Y, Lee WY, Koay WI, Tay SZ, Soon D, et al. A pilot study to examine the correlation between cognition and blood biomarkers in a Singapore Chinese male cohort with type 2 diabetes mellitus. PLoS One. 2014;9, e96874.
18. Umegaki H, Iimuro S, Shinozaki T, Araki A, Sakurai T, Iijima K, et al. Risk factors associated with cognitive decline in the elderly with type 2 diabetes: baseline data analysis of the Japanese elderly diabetes intervention trial. Geriatr Gerontol Int. 2012;12:103-9.
19. Umegaki H, Iimuro S, Shinozaki T, Araki A, Sakurai T, Iijima K, et al. Risk factors associated with cognitive decline in the elderly with type 2 diabetes: pooled logistic analysis of a 6 year observation in the Japanese elderly diabetes intervention trial. Geriatr Gerontol Int. 2012;12:110-6.
20. Xia W, Wang S, Sun Z, Bai F, Zhou Y, Yang Y, et al. Altered baseline brain activity in type 2 diabetes: a resting-state fMRI study. Psychoneuroendocrinology. 2013;38:2493-501.
21. Zhou H, Lu W, Shi Y, Bai F, Chang J, Yuan Y, et al. Impairments in cognition and resting-state connectivity of the hippocampus in elderly subjects with type 2 diabetes. Neurosci Lett. 2010;473:5-10.
22. Biswal B, Zerrin Yetkin F, Haughton VM, Hyde JS. Functional connectivity in the motor cortex of resting human brain using echo-planar mri. Magn Reson Med. 1995;34:537-41.
23. Raichle ME, Macleod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL. A default mode of brain function. Proc Natl Acad Sci. 2001;98:676-82.
24. Musen G, Jacobson AM, Bolo NR, Simonson DC, Shenton ME, McCartney RL, et al. Resting-state brain functional connectivity is altered in type 2 diabetes. Diabetes. 2012;61:2375-9.
25. Scheltens P, Kittner B. Preliminary results from an MRI/CT based database for vascular dementia and Alzheimer's disease. Ann N Y Acad Sci. 2000;903:542-6.
26. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-421.
27. Haley AP, Forman DE, Poppas A, Hoth KF, Gunstad J, Jefferson AL, et al. Carotid artery intima-media thickness and cognition in cardiovascular disease. Int J Cardiol. 2007;121:148-54.
28. Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry CP, Yaffe K. Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ. 2005;330:1360.
29. Berkman LF, Seeman TE, Albert M, Blazer D, Kahn R, Mohs R, et al. High, usual and impaired functioning in community-dwelling older men and women: findings from the MacArthur Foundation Research Network on Successful Aging. J Clin Epidemiol. 1993;46:1129-40.
30. Lassek WD, Gaulin SJ. Waist-hip ratio and cognitive ability: is gluteofemoral fat a privileged store of neurodevelopmental resources? Evol Hum Behav. 2008;29:26-34.
31. Waldstein S, Katzel L. Interactive relations of central versus total obesity and blood pressure to cognitive function. Int J Obes. 2005;30:201-7.
32. Gunstad J, Lhotsky A, Wendell CR, Ferrucci L, Zonderman AB. Longitudinal examination of obesity and cognitive function: results from the Baltimore longitudinal study of aging. Neuroepidemiology. 2010;34:222-9.
33. Jagust W, Harvey D, Mungas D, Haan M. Central obesity and the aging brain. Arch Neurol. 2005;62:1545.
34. He X-S, Wang Z-X, Zhu Y-Z, Wang N, Hu X, Zhang D-R, et al. Hyperactivation of working memory-related brain circuits in newly diagnosed middle-aged type 2 diabetics. Acta Diabetol. 2014;1-10.
35. Wang C-X, Fu K-L, Liu H-J, Xing F, Zhang S-Y. Spontaneous brain activity in type 2 diabetics revealed by amplitude of Low-frequency fluctuations and its association with diabetic vascular disease: a resting-state fMRI study. PLoS One. 2014;9, e108883.
36. Marder TJ, Flores VL, Bolo NR, Hoogenboom WS, Simonson DC, Jacobson AM, et al. Task-induced brain activity patterns in type 2 diabetes: a potential biomarker for cognitive decline. Diabetes. 2014;63(9):3112-9.
37. Alberti KGMM, Zimmet P. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med. 1998;15:539-53.
38. The American Diabetes Association. Introduction. Diabetes Care. 2015;38 Suppl:S1-2.
39. Van den Berg E, Reijmer Y, De Bresser J, Kessels R, Kappelle L, Biessels G, et al. A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus. Diabetologia. 2010;53:58-65.
40. Wahlund L, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjögren M, et al. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke. 2001;32:1318-22.
41. Chao-Gan Y, Yu-Feng Z. DPARSF: a MATLAB toolbox for "pipeline" data analysis of resting-state fMRI. Front Syst Neurosci. 2010;4.
42. Lowe M, Mock B, Sorenson J. Functional connectivity in single and multislice echoplanar imaging using resting-state fluctuations. Neuroimage. 1998;7:119-32.
43. Forman SD, Cohen JD, Fitzgerald M, Eddy WF, Mintun MA, Noll DC. Improved assessment of significant activation in functional magnetic resonance imaging (fMRI): use of a cluster size threshold. Magn Reson Med. 1995;33:636-47.